CANADIAN LEAGUE AGAINST EPILEPSY

What CANADIAN LEAGUE AGAINST EPILEPSY does

Canadian League Against Epilepsy (CLAE) is a registered Canadian non-profit professional medical society founded in 1977 and headquartered in Markham, Ontario. It functions as the national chapter of the International League Against Epilepsy (ILAE) and serves as the unified convening body for Canadian clinicians, researchers, and trainees working in epilepsy. Its core programs include the Annual Scientific Meeting (a rotating national conference accredited by the Royal College of Physicians and Surgeons of Canada for 12-13.5 MOC Section 1 credits), the Canadian Epilepsy Teaching Network (CETN), a Canadian EEG Teaching Program, an Epilepsy Fellows' Monthly Journal Club, a Mentorship Program, and a portfolio of awards (Camfield, Wilder Penfield, Junior Investigator, Excellence in Research/Education, Clinical Practice/Advocacy, and others). CLAE operates three wholly-owned research and education subsidiaries: the Canadian Epilepsy Research Initiative (CERI, founded 2001, 170+ members), the Canadian Paediatric Epilepsy Network (CPEN), and the Canadian Epilepsy Teaching Network (CETN).

CLAE's business model is a classic professional society structure. Revenue is generated from three streams: annual membership dues across tiered categories (Full Member MD/PhD at $200 CAD, Allied Health at $60 CAD, Junior Associate at $50 CAD, Senior Associate at no fee); conference registration fees for the Annual Scientific Meeting (tiered by member status and professional category, with early-bird rates and separate fees for physicians, scientists, healthcare providers, and trainees); and sponsorships from pharmaceutical and medical device companies (UCB, Eisai, Sunovion, LivaNova, Jazz Pharmaceuticals, others) and from the Savoy Foundation, which has distributed over $10 million in epilepsy research grants since 1971. Distribution is self-serve through the Wild Apricot-powered website at claegroup.org, with Google, Microsoft, or Apple login for membership. The organization targets four primary member personas — physicians (neurologists, epileptologists, neurosurgeons), researchers and scientists, trainees and fellows, and allied health professionals — and uses a community-led go-to-market motion driven by conferences, education events, and professional referrals. Revenue is not publicly disclosed; the organization is membership-governed, not venture-backed, and operates as a registered Canadian charity.

Name

CANADIAN LEAGUE AGAINST EPILEPSY

Legal name

Canadian League Against Epilepsy

Website

https://claegroup.org

Company type

Private

Founded year

1977

Operating status

Operating

Short description

Canadian League Against Epilepsy (CLAE) is a non-profit professional medical society and Canadian chapter of the International League Against Epilepsy, serving physicians, researchers, trainees, and allied health professionals working in epilepsy through accredited education, annual scientific meetings, and research networks.

Ownership category

akta.pro rank

Product category

Professional Medical Society / Healthcare Professional Association

NAICS

Professional Organizations (81392), Business, Professional, Labor, Political, and Similar Organizations (8139)

SIC

Services-Membership Organizations (8600), Services-Educational Services (8200)

akta.pro primary industry

Education Professionals (Teacher/Administrator CE, CPD) (EDAAALAE)

akta.pro secondary industries

Clinical Research Support (CRC/CTA) (EDAOAJAO), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Epilepsy professional society
• Continuing medical education
• Clinical research network
• Scientific conferences
• Medical professional membership

Headquarters

HQ city

Markham

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership Dues: CLAE generates revenue through annual membership dues from various membership categories including Full Members (MD and PhD), Allied Health Care Professional Associates, and Junior Associates. The membership cycle runs from July 1st to June 30th.
2. Conference Registration Fees: Revenue generated from registration fees for the Annual Scientific Meeting, with tiered pricing for members and non-members across various professional categories including physicians, scientists, trainees, and healthcare providers.
3. Sponsorships: The organization receives support from pharmaceutical companies and medical device companies as sponsors and exhibitors at the Annual Scientific Meeting, including companies such as UCB, Eisai, Sunovion, LivaNova, Jazz Pharmaceuticals, and others.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

The Canadian League Against Epilepsy (CLAE) is a non-profit professional society that delivers continuing medical education, research collaboration programs, mentorship, and annual scientific meetings to physicians, researchers, trainees, and allied health professionals working in epilepsy care across Canada. It operates membership tiers, educational networks (CETN, EEG Teaching Program), research initiatives (CERI, CPEN), fellowship directories, and an awards program, with revenue drawn from membership dues, conference registration fees, and pharmaceutical sponsorships.

Product overview

The Canadian League Against Epilepsy (CLAE) is a professional medical society that serves as a platform for epilepsy professionals, offering educational programs, research initiatives, annual scientific meetings, and member services. The organization operates through multiple interconnected programs: an Annual Scientific Meeting (ASM) as its flagship event, the Canadian Epilepsy Teaching Network (CETN) providing monthly virtual education rounds and EEG teaching courses, an Epilepsy Fellows' Monthly Journal Club for postgraduate education, a Mentorship Program linking mentors with mentees, the Canadian Epilepsy Research Initiative (CERI) connecting researchers across Canada, and the Canadian Paediatric Epilepsy Network (CPEN) for pediatric-focused collaborative research. These programs are supported by membership tiers (Full Member, Allied Health Care Professional Associate, Junior Associate, Senior Associate) and various awards recognizing excellence in epilepsy research and clinical practice.

Differentiator

Problem solved

Functional benefit

Products and services

• Annual Scientific Meeting (ASM) The flagship annual conference bringing together epilepsy professionals across Canada for scientific presentations, networking, awards, and accredited continuing medical education (MOC Section 1 credits). Rotates across Canadian cities and serves as the organization's primary recruitment and engagement event.
• Canadian Epilepsy Teaching Network (CETN) National virtual education program providing monthly rounds on epilepsy topics and EEG teaching, following the ILAE competency-based curriculum. Available to CLAE members across Canada.
• Canadian EEG Teaching Program A two-day intensive course teaching EEG interpretation, covering normal patterns, abnormal patterns, neonatal EEG, and ICU monitoring techniques. Targeted at neurology trainees and practitioners.
• Epilepsy Fellows' Monthly Journal Club Monthly virtual journal club for epilepsy fellows across Canada, fostering collaboration, mentorship, and post-graduate epilepsy education.
• Mentorship Program Program connecting mentors with prospective mentees to foster networking and career growth for early career and junior members.
• Canadian Epilepsy Research Initiative (CERI) Research network organized in 2001 connecting 170+ epilepsy researchers across Canada, promoting research to funding organizations (including CIHR), industry, and the public.
• Canadian Paediatric Epilepsy Network (CPEN) Network of Canadian investigators focused on paediatric epilepsy research, promoting collaborative research on pathogenesis, causes, diagnosis, management, and impact on children.
• Fellowship Opportunities Directory Directory of epilepsy fellowship opportunities across Canadian universities for adult and pediatric epilepsy training programs.
• CLAE Awards Program Recognition programs recognizing epilepsy research and clinical excellence, including the Camfield Award, Publication Awards, Junior Investigator Award, Wilder Penfield Award, and conference abstract awards.
• CLAE Professional Membership Annual professional membership granting access to CLAE programs, publications, and benefits. Four tiers based on professional category with pricing scaled to career stage.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered core and minor.

• International League Against Epilepsy (ILAE)coreStrategic or Co-development PartnerCLAE is the Canadian chapter of the ILAE, a global organization dedicated to epilepsy research, education, and care. This affiliation provides CLAE members with access to international resources, collaborative research opportunities, and global epilepsy community connections.
• Canadian Epilepsy AlliancecoreStrategic or Co-development PartnerCLAE works closely with the Canadian Epilepsy Alliance, an advocacy organization, to improve epilepsy care and awareness across Canada. The two organizations collaborate on public education and policy advocacy.
• Canadian Paediatric Epilepsy Network (CPEN)coreStrategic or Co-development PartnerCPEN is a committee of CLAE focused on paediatric epilepsy research. It promotes, facilitates and engages in collaborative research to advance understanding of paediatric epilepsy regarding pathogenesis, causes, natural history, diagnosis, management, and impact on children.
• Canadian Epilepsy Research Initiative (CERI)coreStrategic or Co-development PartnerCERI was organized in 2001 as a research section of CLAE, connecting epilepsy researchers across Canada to promote research to funding organizations including CIHR, industry, and the public. Network comprises over 170 members.
• EisaiminorOthersPharmaceutical company providing platinum and gold sponsorship support for CLAE Annual Scientific Meetings.
• UCBminorOthersPharmaceutical company providing sponsorship and exhibitor support for CLAE Annual Scientific Meetings.
• LivaNovaminorOthersMedical device company providing exhibitor and sponsor support for CLAE Annual Scientific Meetings.
• SunovionminorOthersPharmaceutical company providing sponsorship support for CLAE Annual Scientific Meetings.
• Jazz PharmaceuticalsminorOthersPharmaceutical company providing sponsor support for CLAE Annual Scientific Meetings.
• Project ECHO OntariominorStrategic or Co-development PartnerTechnology-enabled collaborative CPD-accredited learning program that CLAE members can access for epilepsy education across the lifespan. Partners community healthcare providers with epilepsy specialists.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Regional players

• European Academy of Neurology: European regional neurology society offering CME and an annual congress; mirrors CLAE's model of accredited neurology education but serves European members rather than competing in Canada.

Direct peers

• International League Against Epilepsy (ILAE): Global professional society for epilepsy of which CLAE is the Canadian chapter; operates the same model of CME, research coordination, and consensus statements, providing direct mission and operational alignment.
• International Bureau for Epilepsy (IBE): International epilepsy-focused umbrella organization with social and patient-advocacy remit; structurally similar to a national league and closely linked with ILAE in the global epilepsy ecosystem.
• Epilepsy Canada: Canadian epilepsy-focused organization partnered with CLAE; similar national footprint in Canada, overlapping mission around epilepsy research funding and awareness, though with a different mix of research vs. advocacy.
• American Epilepsy Society: The US counterpart professional society for epilepsy clinicians and researchers; runs an annual meeting, CME programs, and research awards with a comparable membership society structure.
• Canadian Neurological Society: Broader Canadian neurology professional society; comparable national membership-society model with annual scientific meeting, CME accreditation, and CME Section 1 credit offering for Canadian neurologists.

Broad incumbents

• American Academy of Neurology: Large US neurology professional society with overlapping CME, journal, and annual meeting offerings; covers epilepsy as one of many neurology subspecialties, representing the broader incumbent in the field.
• Canadian Medical Association: Umbrella Canadian medical professional society; operates a comparable membership and conference model at much greater scale across all physician specialties, representing the broad incumbent against which subspecialty societies like CLAE are positioned.

Others

• Royal College of Physicians and Surgeons of Canada: Accreditation body for the MOC Section 1 credits CLAE earns; not a competitor but a critical enabler of CLAE's CME value proposition and therefore a structurally important peer relationship.

Emerging players

• Child Neurology Society: Pediatric-focused neurology society with comparable annual meeting and CME accreditation model; overlaps with CLAE's CPEN initiative on pediatric epilepsy research and education.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/CLAE_LCCE

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CANADIAN LEAGUE AGAINST EPILEPSY